BCL10 抗体 (N-Term) (APC)
Our Local Distributor
北京 101111
Quick Overview for BCL10 抗体 (N-Term) (APC) (ABIN2209255)
抗原
See all BCL10 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 27-55, N-Term
-
交叉反应
- 人, 小鼠
-
交叉反应 (详细)
- Calculated cross reactivity: Hu Mo
-
产品特性
- BCL10, NT (BCL10, CIPER, CLAP, B Cell lymphoma/leukemia 10, B Cell CLL/lymphoma 10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN, Cellular-E10, Mammalian CARD-containing adapter molecule E10) (APC)
-
纯化方法
- Purified by Protein A affinity chromatography.
-
免疫原
- BCL10 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 27-55 amino acids from the N-terminal region of human BCL10.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working conditions should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Supplied as a liquid in PBS, pH 7.2.
-
储存条件
- 4 °C
-
储存方法
- 4°C ,Do Not Freeze
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
别名
- BCL10
-
NCBI登录号
- NP_003912
-
UniProt
- O95999
-
途径
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
抗原
-